Trump and RFK Jr.’s claims linking Tylenol to autism are false, spread fear, and undermine trust in public health. This ...
Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during ...
Barchart on MSN
Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.
Kenvue (KVUE) could really use some good news. The Johnson & Johnson (JNJ) spinoff faced longlasting troubles regarding its ...
Kenvue, the American company that makes Tylenol, says the U.S. Food and Drug Administration should not make proposed changes ...
The push for a label change came after President Donald Trump held a news conference last month in which he told pregnant ...
Kenvue Inc. offers stable financials, robust 5% dividend yield, and trades at a significant discount to peers. Learn more ...
The presidential spotlight created a public relations firestorm for Kenvue, which has a market value of roughly $30 billion.
Tylenol maker Kenvue was already having a painful year before U.S. President Donald Trump and his health secretary got involved.
Tylenol is known by the generic name acetaminophen in the US or paracetamol in other countries. The Trump admin has lately linked its use to pregnancy risks.
Claims from the Trump White House about links between use of the painkiller acetaminophen – often sold under the brand name Tylenol in the U.S. – during pregnancy and development of autism have set ...
WASHINGTON – Health Secretary Robert F. Kennedy Jr. expanded his crusade against using Tylenol with a warning: boys who were circumcised were twice as likely to be diagnosed with autism later. "There ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results